Share chart Enlivex Therapeutics Ltd.
Extended chart
Simple chart
About Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd. operates as a clinical-stage macrophage reprogramming immunotherapy company. It is developing Allocetra, a cell-based therapy to treat organ dysfunction and failure associated with sepsis that is in phase II clinical trial, as well as in preclinical trial to treat solid tumors. The company has a collaboration agreement with BeiGene to evaluate the safety and efficacy of Allocetra in combination with tislelizumab, an anti-PD-1 immune checkpoint inhibitor for the treatment of patients with advanced-stage solid tumors. Enlivex Therapeutics Ltd. more details| IPO date | 1995-12-12 |
|---|---|
| ISIN | IL0011319527 |
| Industry | Software |
| Sector | Information Technology |
| Валюта | usd |
| Валюта отчета | usd |
| Сайт | https://www.enlivex.com |
| Цена ао | 3.91 |
| Change price per day: | -4.8% (1.25) |
|---|---|
| Change price per week: | -4.03% (1.24) |
| Change price per month: | +4.39% (1.14) |
| Change price per 3 month: | -27.44% (1.64) |
| Change price per half year: | -9.98% (1.322) |
| Change price per year: | -55.93% (2.7) |
| Change price per 3 year: | -81.17% (6.32) |
| Change price per 5 year: | -84.86% (7.86) |
| Change price per 10 year: | 0% (1.19) |
| Change price per year to date: | -3.25% (1.23) |
|
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
|||||||||||||||||||||||||||||||||||||
| Institutions | Volume | Share, % |
|---|---|---|
| Renaissance Technologies, LLC | 62089 | 0.33 |
| Morgan Stanley | 44460 | 0.24 |
| Susquehanna International Group, LLP | 27925 | 0.15 |
| Edmond De Rothschild Holding S.A. | 13000 | 0.07 |
| Geode Capital Management, LLC | 10420 | 0.06 |
| Wells Fargo & Company | 9993 | 0.05 |
| Citadel Advisors Llc | 7086 | 0.04 |
| Citigroup Inc. | 4724 | 0.03 |
| UBS Group AG | 3663 | 0.02 |
| Steward Partners Investment Advisory, LLC | 3000 | 0.02 |
| Head | Job title | Payment | Year of birth |
|---|---|---|---|
| Mr. Shai Novik M.B.A. | Executive Chairman | 528k | 1966 (59 years) |
| Dr. Oren Hershkovitz Ph.D. | Chief Executive Officer | 273.6k | 1977 (48 years) |
| Mr. Veronique Amor-Baroukh | Senior Director of Operations | N/A | |
| Ms. Sigal Arad | Director of HR | N/A |
Address: Israel, Ness Ziona, 14 Einstein Street - open in Google maps, open in Yandex maps
Website: https://www.enlivex.com
Website: https://www.enlivex.com
